167 related articles for article (PubMed ID: 33451857)
21. Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases.
McPartlin A; Swaminath A; Wang R; Pintilie M; Brierley J; Kim J; Ringash J; Wong R; Dinniwell R; Craig T; Dawson LA
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):388-395. PubMed ID: 28871989
[TBL] [Abstract][Full Text] [Related]
22. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic radiotherapy of targets in the lung and liver.
Wulf J; Hädinger U; Oppitz U; Thiele W; Ness-Dourdoumas R; Flentje M
Strahlenther Onkol; 2001 Dec; 177(12):645-55. PubMed ID: 11789403
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters.
Flamarique S; Campo M; Asín G; Pellejero S; Viúdez A; Arias F
Clin Transl Oncol; 2020 Dec; 22(12):2350-2356. PubMed ID: 32488803
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
Chang DT; Swaminath A; Kozak M; Weintraub J; Koong AC; Kim J; Dinniwell R; Brierley J; Kavanagh BD; Dawson LA; Schefter TE
Cancer; 2011 Sep; 117(17):4060-9. PubMed ID: 21432842
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic body radiation therapy for colorectal liver metastases.
van der Pool AE; Méndez Romero A; Wunderink W; Heijmen BJ; Levendag PC; Verhoef C; Ijzermans JN
Br J Surg; 2010 Mar; 97(3):377-82. PubMed ID: 20095016
[TBL] [Abstract][Full Text] [Related]
28. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
29. Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.
Ohri N; Tomé WA; Méndez Romero A; Miften M; Ten Haken RK; Dawson LA; Grimm J; Yorke E; Jackson A
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):188-195. PubMed ID: 29395629
[TBL] [Abstract][Full Text] [Related]
30. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.
Clerici E; Comito T; Franzese C; Di Brina L; Tozzi A; Iftode C; Navarria P; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
Strahlenther Onkol; 2020 Apr; 196(4):325-333. PubMed ID: 31605163
[TBL] [Abstract][Full Text] [Related]
31. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
Klement RJ; Abbasi-Senger N; Adebahr S; Alheid H; Allgaeuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Eble MJ; Ernst I; Gerum S; Habermehl D; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lewitzki V; Lohaus F; Ostheimer C; Papachristofilou A; Petersen C; Rieber J; Schneider T; Schrade E; Semrau R; Wachter S; Wittig A; Guckenberger M; Andratschke N
BMC Cancer; 2019 Feb; 19(1):173. PubMed ID: 30808323
[TBL] [Abstract][Full Text] [Related]
32. Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.
Hong TS; Wo JY; Borger DR; Yeap BY; McDonnell EI; Willers H; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Tanguturi S; Goyal L; Murphy JE; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Tanabe KK; Ferrone CR; Ryan DP; Iafrate AJ; DeLaney TF; Zhu AX
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954285
[TBL] [Abstract][Full Text] [Related]
33. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
[TBL] [Abstract][Full Text] [Related]
34. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis.
Franzese C; Fogliata A; Comito T; Tozzi A; Iftode C; Clerici E; Franceschini D; Navarria P; Ascolese AM; Di Brina L; De Rose F; D'Agostino GR; Cozzi L; Scorsetti M
Br J Radiol; 2017 Nov; 90(1079):20170422. PubMed ID: 28869396
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
38. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic radiotherapy of primary liver cancer and hepatic metastases.
Wulf J; Guckenberger M; Haedinger U; Oppitz U; Mueller G; Baier K; Flentje M
Acta Oncol; 2006; 45(7):838-47. PubMed ID: 16982548
[TBL] [Abstract][Full Text] [Related]
40. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
Eriguchi T; Takeda A; Sanuki N; Oku Y; Aoki Y; Shigematsu N; Kunieda E
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1006-11. PubMed ID: 23102838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]